Neoadjuvant Therapy

Neoadjuvant Therapy is a form of oncologic treatment that is administered before the primary local or definitive therapy (such as surgery or radiotherapy) to reduce tumor burden, improve resectability, and thereby enhance the overall efficacy of the treatment plan.

7.7K

Publications

498.1K

Citations

44.5K

Authors

5.4K

Institutions

Publications per year

2017–2026

3.3K

Authors

44.5K

  1. SL
    Sibylle Loibl

    German Breast group, Germany

    89 publications · 16.2K citations

    48

    h-index

  2. GN
    Gabriel N. Hortobágyi

    The University of Texas MD Anderson Cancer Center, United States

    72 publications · 16.4K citations

    47

    h-index

  3. MU
    Michael Untch

    Helios Hospital Berlin-Buch, Germany

    91 publications · 15K citations

    45

    h-index

  4. GV
    Gϋnter von Minckwitz

    German Breast group, Germany

    81 publications · 15.8K citations

    44

    h-index

  5. JB
    Jens‐Uwe Blohmer

    Charité - Universitätsmedizin Berlin, Germany

    65 publications · 14.3K citations

    42

    h-index

1–5 of 44.5K

Venues

  1. Journal of Clinical Oncology

    586 publications · 75.9K citations

    136

    h-index

  2. Annals of Surgical Oncology

    406 publications · 23.9K citations

    81

    h-index

  3. Annals of Oncology

    214 publications · 18.7K citations

    75

    h-index

  4. Cancer

    181 publications · 16.8K citations

    74

    h-index

  5. Annals of Surgery

    120 publications · 15.9K citations

    63

    h-index

1–5